"Patents for Second Medical Indications: Issues and Implications for Pharmacare in Canada" (March 26, 2001). Report prepared for Health Canada.
Monday, 26 March 2001 09:55
Patents for Second Medical Indications: Issues and Implications for Pharmacare in Canada
Written by Teresa Scassa-
font size
decrease font size
increase font size
Latest from Teresa Scassa
- Crafting a More Nuanced Right to an Explanation in Administrative Law: A comment on Ali v. Minister of Public Safety and Emergency Preparedness
- Investigation into use of personal health information for research leaves core issue unresolved
- Submission to Consultation on Ontario's Bill 194: Strengthening Cyber Security and Building Trust in the Public Sector Act, 2024
- Privacy for the Digital Age: The Supreme Court of Canada's decision in R. v. Bykovets
- BC Court Confirms Application of Provincial Privacy Law to Federal Political Parties